BioDiscovery is a scientific software company based in El Segundo, California, focused on genetic research and genomic analysis. Industry peers in 2002 included Silicon Genetics, Omnigon, and Geneformatics.
BioDiscovery's software product consists of three umbrella offerings: Nexus Copy Number (for microarray and NGS copy number analysis), NxClinical (for CNV analysis and visualization), Nexus Expression (for microarray and NGS gene expression) and ImaGene (machine vision microarray analysis).
In addition, the company hosts Nexus DB (using Amazon's AWS as of October 2011), which is a cloud-based collaborative extension to the Nexus product line.
The company's "GeneDirector" software has been described as "a comprehensive microarray data-management solution", including support for workflow processes, sample management and automated image analysis. Software modules support integration with microarray instruments, such as those from Agilent and Affymetrix.
BioDiscovery was founded in 1997 in Los Angeles, California, and has been focused on analyzing data from high-throughput microarrays and next-generation sequencing (NGS). The company's present headquarters are in El Segundo, California.
The company became embroiled in a legal battle with the Canadian firm GSI Lumonics in 1999 over purported breach of contract by GSI in using BioDiscovery trade secrets instantiated in ImaGene software in their own software, with a countersuit by GSI claiming defamation; all litigation was settled in late 2000. This suit began against defendant General Scanning, based in Boston, which had been acquired by GSI Lumonics in March 1999.
In 2002, BioDiscovery was one of seven firms sued by Oxford Gene Technology for unlicensed usage of gene-chip technology invented by Edwin Southan, patented by Oxford in 2000. In 2014, the company partnered with N-of-One "to provide integrated genomic analysis interpretation solutions", aimed use of genomic data by clinicians.